Good point Adam, that’s how significantly undervalued IHL is.
The only other company in the space that has 4 clinical trials planned is BDA and they are capped today at $85 million which is about 5 times that of IHL.
Interestingly their 4 trials relate to skin conditions such as psoriasis, acne and eczema.
I might just point out that one of AXIM’s more advanced products is a cream for psoriasis and dermatitis. Given that IHL have recently announced they have exclusivity over AXIM’s products for 3 years if I were them I’d be looking at that as the next product offering.
Ted
- Forums
- ASX - By Stock
- IHL
- IHL Value
IHL Value, page-2
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online